February 28, 2023 — 04:16 pm EST

      Written by
                        RTTNews.com for                             
        




RTTNews ->


(RTTNews) - Myriad Genetics Inc. (MYGN) released Loss for its fourth quarter that increased from last year and  missed the Street estimates.
The company's earnings came in at -$42.3 million, or -$0.52 per share.  This compares with -$7.6 million, or -$0.10 per share, in last year's fourth quarter.
Excluding items, Myriad Genetics Inc. reported adjusted earnings of -$9.7 million or -$0.12 per share for the period. 
Analysts on average had expected the company to earn -$0.16 per share, according to figures compiled by Thomson Reuters.  Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 10.6% to $177.8 million from $160.8 million last year.
Myriad Genetics Inc. earnings at a glance (GAAP) :
-Earnings (Q4): -$42.3 Mln. vs. -$7.6 Mln. last year.
-EPS (Q4): -$0.52 vs. -$0.10 last year.
-Analyst Estimate: -$0.16
-Revenue (Q4): $177.8 Mln vs. $160.8 Mln last year.
 -Guidance:
Next quarter EPS guidance: $(0.20) - $(0.18)
Next quarter revenue guidance: $170 - $172 Mln
 
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

© 2023, Nasdaq, Inc. All Rights Reserved.










To add symbols:


These symbols will be available throughout the site during your session.
To add symbols:


These symbols will be available throughout the site during your session.